The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
Open accessAbstract
BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracentrifugation was performed to isolate extracellular vesicles (EVs) based on their size from vehicle- or gemcitabine-treated PC cells. Extracellular vesicles size and subtypes were determined by dynamic light scattering and marker profiling, respectively. Gene expression was examined by qRT-PCR and/or immunoblot analyses, and direct targeting of DCK by miR-155 was confirmed by dual-luciferase 3'-UTR reporter assay. Flow cytometry was performed to examine the apoptosis indices and reactive oxygen species (ROS) levels in PC cells using specific dyes. Cell viability was determined using the WST-1 assay. RESULTS: Conditioned media (CM) from gemcitabine-treated PC cells (Gem-CM) provided significant chemoprotection to subsequent gemcitabine toxicity and most of the chemoresistance conferred by Gem-CM resulted from its EVs fraction. Sub-fractionation grouped EVs into distinct subtypes based on size distribution and marker profiles, and exosome (Gem-Exo) was the only sub-fraction that imparted chemoresistance. Gene expression analyses demonstrated upregulation of SOD2 and CAT (ROS-detoxifying genes), and downregulation of DCK (gemcitabine-metabolising gene) in Gem-Exo-treated cells. SOD/CAT upregulation resulted, at least in part, from exosome-mediated transfer of their transcripts and they suppressed basal and gemcitabine-induced ROS production, and partly promoted chemoresistance. DCK downregulation occurred through exosome-delivered miR-155 and either the functional suppression of miR-155 or restoration of DCK led to marked abrogation of Gem-Exo-mediated chemoresistance. CONCLUSIONS: Together, these findings establish a novel role of exosomes in mediating the acquired chemoresistance of PC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207272 · Cited by 224
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Self-citationMoore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Reactive oxygen species in cancer
Liou, G.-Y., & Storz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,382
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Self-citationExosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Qu, L., Ding, J., Chen, C., Wu, Z.-J., Liu, B., Gao, Y., Chen, W., Liu, F., Sun, W., Li, X.-F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.004 · Cited by 1,117
Quantitative and stoichiometric analysis of the microRNA content of exosomes
Chevillet, J. R., Kang, Q., Ruf, I. K., Briggs, H. A., Vojtech, L. N., Hughes, S. M., Cheng, H. H., Arroyo, J. D., Meredith, E. K., Gallichotte, E. N., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408301111 · Cited by 1,096
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Gironella, M., Seux, M., Xie, M.-J., Cano, C., Tomasini, R., Gommeaux, J., Garcia, S., Nowak, J., Yeung, M. L., Jeang, K.-T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703942104 · Cited by 551
Gemcitabine resistance in pancreatic ductal adenocarcinoma
Binenbaum, Y., Na’ara, S., & Gil, Z. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.002 · Cited by 414
Castells, M., Thibault, B., Delord, J.-P., & Couderc, B. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13089545 · Cited by 285
Donadelli, M., Dando, I., Zaniboni, T., Costanzo, C., Dalla Pozza, E., Scupoli, M. T., Scarpa, A., Zappavigna, S., Marra, M., Abbruzzese, A., et al. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.36 · Cited by 228
Singh, S., Srivastava, S. K., Bhardwaj, A., Owen, L. B., & Singh, A. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605968 · Cited by 225
Self-citationShi, X., Liu, S., Kleeff, J., Friess, H., & Büchler, M. W. (2002) · Oncology · doi:10.1159/000065068 · Cited by 177
Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
Kim, M. P., & Gallick, G. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2247 · Cited by 177
An Undesired Effect of Chemotherapy
Arora, S., Bhardwaj, A., Singh, S., Srivastava, S. K., McClellan, S., Nirodi, C. S., Piazza, G. A., Grizzle, W. E., Owen, L. B., & Singh, A. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484576 · Cited by 166
Self-citationWu, H., Zhiyong, L., Xiaohua, S., Xinyu, R., Wang, K., & Tonghua, L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-125 · Cited by 157
Singh, A. P., Arora, S., Bhardwaj, A., Srivastava, S. K., Kadakia, M., Wang, B., Grizzle, W. E., Owen, L. B., & Singh, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409581 · Cited by 122
Self-citationDCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells
Saiki, Y., Yoshino, Y., Fujimura, H., Manabe, T., Kudo, Y., Shimada, M., Mano, N., Nakano, T., Lee, Y., Shimizu, S., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.122 · Cited by 114
Ohhashi, S., Ohuchida, K., Mizumoto, K., Fujita, H., Egami, T., Yu, J., Toma, H., Sadatomi, S., Nagai, E., & Tanaka, M. (2008) · PubMed · Cited by 111
Recent studies of 5-fluorouracil resistance in pancreatic cancer
Wang, W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i42.15682 · Cited by 102
MicroRNA-based Cancer Therapeutics: Big Hope from Small RNAs
Bhardwaj, A., Singh, S., & Singh, A. (2010) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.10.27 · Cited by 97
Self-citationSong, X. J., Ding, Y., Liu, G., Xiao, Y., Zhao, R., Zhang, Y., Zhao, X. L., Anderson, G. J., & Nie, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716316 · Cited by 95
Hosseini‐Beheshti, E., Choi, W. W. Y., Weiswald, L., Kharmate, G., Ghaffari, M., Roshan‐Moniri, M., Hassona, M. D. H., Chan, L., Chin, M. Y., Tai, I. T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7052 · Cited by 94
Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge
Hung, S. W., Mody, H. R., & Govindarajan, R. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.007 · Cited by 88
Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer
Rodríguez, M., Silva, J., Herrera, A., Herrera, M., Peña, C., Martín, P., Gil-Calderón, B., Larriba, M. J., Coronado, M. J., Soldevilla, B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5818 · Cited by 86
Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine
Dalla Pozza, E., Fiorini, C., Dando, I., Menegazzi, M., Sgarbossa, A., Costanzo, C., Palmieri, M., & Donadelli, M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.007 · Cited by 84
Smarter drugs emerging in pancreatic cancer therapy
Kleger, A., Perkhofer, L., & Seufferlein, T. T. W. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu013 · Cited by 78
Xu, X., Wells, A. C., Padilla, M. T., Kato, K., Kim, K. C., & Lin, Y. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu159 · Cited by 75
Bhardwaj, A., Srivastava, S. K., Singh, S., Arora, S., Tyagi, N., Andrews, J., McClellan, S. B., Carter, J. E., & Singh, A. P. (2014) · Oncotarget · doi:10.18632/oncotarget.2571 · Cited by 71
Self-citationSrivastava, S. K., Bhardwaj, A., Arora, S., Tyagi, N., Singh, S., Andrews, J., McClellan, S., Wang, B., & Singh, A. P. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.252 · Cited by 70
Self-citationAmit, M., & Gil, Z. (2013) · OncoImmunology · doi:10.4161/onci.27231 · Cited by 64
MicroRNAs in pancreatic malignancy: Progress and promises
Srivastava, S. K., Arora, S., Singh, S., Bhardwaj, A., Averett, C., & Singh, A. P. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.015 · Cited by 53
Self-citationMüerköster, S. S., Lust, J. A., Arlt, A., Häsler, R., Witt, M., Sebens, T., Schreiber, S., Fölsch, U. R., & Schäfer, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209423 · Cited by 53
Pancreatic Cancer Exosomes: Shedding Off for a Meaningful Journey
Patel, G. K., & Patton, M. C. (2016) · Pancreatic Disorders and Therapy · doi:10.4172/2165-7092.1000e148 · Cited by 39
Self-citationYeung, B. H. Y., Wong, K. Y., Lin, M. C., Wong, C. K. C., Mashima, T., TSURUO, T., & Wong, A. S. T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604477 · Cited by 31
Khan, M. A., Srivastava, S. K., Bhardwaj, A., Singh, S., Arora, S., Zubair, H., Carter, J. E., & Singh, A. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3784 · Cited by 24
Self-citation
Cited by
Patel, G. K., Khan, M. A., Zubair, H., Srivastava, S. K., Khushman, M., Singh, S., & Singh, A. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-41800-2 · Cited by 640
Self-citationEmerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 563
Extracellular vesicles and anti-cancer drug resistance
Namee, N. M., & O'Driscoll, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.07.003 · Cited by 274
Microvesicles: ROS scavengers and ROS producers
Bodega, G., Alique, M., Puebla, L., Carracedo, J., & Ramírez, R. M. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1626654 · Cited by 258
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Bayraktar, R., & Van Roosbroeck, K. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9724-7 · Cited by 216
Metadata
- Authors
- Patel, G. K., Khan, M. A., Bhardwaj, A., Srivastava, S. K., Zubair, H., Patton, M. C., Singh, S., Khushman, M., & Singh, A. P.
- Venue
- British Journal of Cancer
- Published
- 2017-02
- Volume
- 116
- Issue
- 5
- Pages
- 609-619
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2585340283
- Cited by
- 266
- References
- 46
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.